Drugs / Abl cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00001832 | Aug 1999 → May 2010 | melanoma, metastatic neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Abl cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001832 ↗ |
| Modality | Cell therapy | “adoptive transfer of lymphocytes reactive with shared antigens on their tumors” NCT00001832 ↗ |
| Route | Intravenous | “Abl cells IV = Lymphocytes 10\^9-10\^11 IV over 30 minutes on day 0” NCT00001832 ↗ |